V. Cocquyt

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma

V. Cocquyt, Phillip Blondeel, Herman Depypere et al. · European Journal of Surgical Oncology · 2003 · 150 citations

Medicine, Oncology, Surgery +14

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

V. Cocquyt, Simon Van Belle, Robert Reinhardt et al. · European Journal of Cancer · 2001 · 148 citations

Medicine, Pharmacology, Pharmacotherapy +5

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

Angelo Di Leo, Stephen Chan, Marianne Paesmans et al. · Breast Cancer Research and Treatment · 2004 · 138 citations

Medicine, Oncology, Pharmacology +11

Mutation analysis of P73 and TP53 in Merkel cell carcinoma

Mireille Van Gele, Mourad Kaghad, J. Helen Leonard et al. · British Journal of Cancer · 2000 · 103 citations · Full text

Medicine, Molecular Genetics, Oncology +13

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17